Zevra Therapeutics Stock (NASDAQ: ZVRA) stock price, news, charts, stock research, profile.
You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.
Other companies in Zevra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Zevra Therapeutics has a consensus price target of $21.00.
The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $8.05 last updated January 17, 2025 at 4:00 PM EST.
There are no upcoming dividends for Zevra Therapeutics.
Zevra Therapeutics’s Q4 earnings are confirmed for Thursday, March 27, 2025.
There is no upcoming split for Zevra Therapeutics.
Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.